Clinical Trial Update: Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Bryostatin 1 in patients with ovarian epithelial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: University of Glasgow | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED